new post
StocksRunner logo
mail
search
 
menu
 
Johnson & Johnson
$239.63
-2.31%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

JNJ Stock Analysis & IQ Rating | Johnson & Johnson

 
 

JNJ

 

Johnson & Johnson

$239.63

 
-$5.67 | -2.31%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$251.71
 
 
MKT CAP
$577.48B
 
52W Low
$141.5
 
 
VOL
$9.13M
 
P/E Ratio
20.94
 
 
AVG VOL
$9.40M
 
RSI
 
 
TREND
 
 
 

JNJ Stock IQ

 
lock  Login to see Johnson & Johnson (JNJ) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

JNJ Target Price

 
 
 

Strengths

 
 

JNJ Rewards

 Earnings are forecast to grow

JNJ Rewards

 Upgraded on attractively valued

JNJ Rewards

 Outperform the market

JNJ Rewards

 Investors confidence is positive

 
 

JNJ Price Performance

 
 

$239.99   (-0.15%)

$199.96   (+19.84%)

$190.72   (+25.64%)

$163.63   (+46.45%)

 
 
1year
6month
3month
1month

JNJ Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

JNJ Earnings Sentiment Above analyst estimates
JNJ Earnings Sentiment Reported a strong earnings
JNJ Earnings Sentiment Earnings increase YoY

Rating

×

Rating

JNJ Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

JNJ Momentum Analysis Has been gaining momentum

Activity

×

Activity

JNJ Activity Sentiment Investors confidence is positive
JNJ Activity Sentiment Pays a reliable dividend

Future

×

Future

JNJ Future Sentiment Earnings are forecast to grow
JNJ Future Sentiment Outperform the market
JNJ Future Sentiment Trading below its fair value
JNJ Analysts Opinion

JNJ Analysts opinion is negative and it remained unchanged from the past 3 months

JNJ Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

79%
Consensus Rating
60%
Buy
Opinion
50%
Trend
Score
100%
Potential
Score
JNJ Street Sentiment

JNJ Street Sentiment is extremely bullish and have positive views on the near-term outlook

JNJ Risk Level

JNJ has Low risk level

Risk Indicators

Investors losing confidence
JNJ Risk Level
Low
LOW
HIGH

JNJ Performance Sentiment

Sentiments overview associated with events and the stock performance

79%
Positive
31 out of 39
events present
15%
Negative
6 out of 39
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$223.99
Resistance Price
$248.56
Current Price Range
$239.56
$223.99
$248.56
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
83%
Consensus Rating
STRONG BUY
5
Buy
1
Hold
0
Sell
Date
Action
Rating
Firm

Feb 02, 2026

 

Upgrade

 

Overweight

 

Morgan Stanley

 

Jan 28, 2026

 

Upgrade

 

Overweight

 

Morgan Stanley

 

Dec 17, 2025

 

Price Target Raised

 

Neutral

 

BofA

 

Dec 12, 2025

 

Reiterate

 

Buy

 

Citigroup

 

Dec 12, 2025

 

Reiterate

 

Outperform

 

RBC

 
 
 
JNJ Latest Analysis +
 
 
FAQ About JNJ Stock Insights
 

What is JNJ current stock price?

What are JNJ stock strengths?

What is JNJ Risk Level?

What is JNJ market cap and volume?

What is JNJ current Stock IQ?

Should I buy JNJ stock right now?

Is JNJ a Strong Buy right now?

What does a 'Strong Buy' rating mean for JNJ?

What does a 'Strong Sell' rating mean for JNJ?

What factors influence JNJ's Stock IQ?

 
 
StocksRunner

Explore our JNJ Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored JNJ Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our JNJ Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

JNJ

 

Johnson & Johnson

 
Set Alerts
 
 

Current Price

 

$239.63

 
-$5.67 | -2.31%
 
 
52W High
$251.71
 
 
MKT CAP
$577.48B
 
52W Low
$141.5
 
 
VOL
$9.13M
 
P/E Ratio
20.94
 
 
AVG VOL
$9.40M
 
RSI
 
 
TREND
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

JNJ Price Performance

 
 

$239.99   (-0.15%)

$199.96   (+19.84%)

$190.72   (+25.64%)

$163.63   (+46.45%)

 
 
1year
6month
3month
1month
 

JNJ Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

JNJ Earnings Sentiment Above analyst estimates
JNJ Earnings Sentiment Reported a strong earnings
JNJ Earnings Sentiment Earnings increase YoY

Rating

×

Rating

JNJ Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

JNJ Momentum Sentiment Has been gaining momentum

Activity

×

Activity

JNJ Activity Sentiment Investors confidence is positive
JNJ Activity Sentiment Pays a reliable dividend

Future

×

Future

JNJ Future Sentiment Earnings are forecast to grow
JNJ Future Sentiment Outperform the market
JNJ Future Sentiment Trading below its fair value
JNJ Analysts Opinion

JNJ Analysts opinion is negative and it remained unchanged from the past 3 months

JNJ Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

79%
Consensus Rating
60%
Buy
Opinion
50%
Trend
Score
100%
Potential
Score
JNJ Street Sentiment

JNJ Street Sentiment is extremely bullish and have positive views on the near-term outlook

JNJ Risk Level

JNJ has Low risk level

Risk Indicators

Investors losing confidence
JNJ Risk Level
Low
LOW
HIGH
JNJ Performance Sentiment
Sentiments overview associated with events and the stock performance.
79%
Positive
31 out of 39
events present
15%
Negative
6 out of 39
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$223.99
Resistance Price
$248.56
Current Price Range
$239.56
$223.99
$248.56
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

83%
Consensus Rating
STRONG BUY
5
Buy
1
Hold
0
Sell
Date
Action
Rating
Firm
Feb 02, 2026
Upgrade
Overweight
Morgan Stanley
Jan 28, 2026
Upgrade
Overweight
Morgan Stanley
Dec 17, 2025
Price Target Raised
Neutral
BofA
Dec 12, 2025
Reiterate
Buy
Citigroup
Dec 12, 2025
Reiterate
Outperform
RBC
 
 
 
 

JNJ Stock IQ

 
 
 
lock  Login to unlock Johnson & Johnson (JNJ) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

JNJ Rewards

 Earnings are forecast to grow

JNJ Rewards

 Upgraded on attractively valued

JNJ Rewards

 Outperform the market

JNJ Rewards

 Investors confidence is positive

 
 
 

JNJ Latest Analysis

 
 
 

J&J wins FDA nod for multiple myeloma therapy.

 

Today

$239.63 | -2.31%
 
Activity

Johnson & Johnson launches website for direct-to-consumer sales.

 

Wed Mar 4, 2026

$245.30 | -0.59%
 
Activity

FDA Grants Fast Track Designation To J&Js Nipocalimab For Systemic Lupus Erythematosus . (RTTNews) - Johnson & Johnson (JNJ) on Tuesday said its nipocalimab has been granted Fast Track designation by the United States Food and Drug Administration for the treatment of adults with systemic lupus erythematosus an autoimmune disease that causes inflammation throughout the body.

 

Tue Mar 3, 2026

$246.75 | -0.73%
 
Activity

Zacks Industry Outlook Highlights Eli Lilly Johnson & Johnson Sanofi and Bayer. LLY JNJ SNY and BAYRY ride strong pipelines and M&A momentum as Large-Cap Pharma rebounds in 2026 despite pricing and patent risks.

 

Tue Mar 3, 2026

$246.75 | -0.73%
 
Momentum

2 Reasons Id Happily Hold Johnson & Johnson Through Any Market Crash. Key PointsJohnson & Johnsons diversified healthcare business can thrive even in a downturn.

 

Fri Feb 27, 2026

$248.43 | +2.04%
 
Momentum

Bayer Sues J&J Over Prostate Cancer Treatment Promotion Dispute . (RTTNews) - German pharmaceutical and life sciences major Bayer AG (BAYRY.PK BAYZF.PK) announced that it has filed false advertising suit against Johnson & Johnson or J&J (JNJ) and Janssen Biotech Inc. over the United States drug majors claims regarding NUBEQA for prostate cancer treat

 

Tue Feb 24, 2026

$246.28 | +0.74%
 
Activity

Bayer sues Johnson & Johnson over prostate cancer drug claims.

 

Tue Feb 24, 2026

$246.28 | +0.74%
 
Activity
 
 
 
 
 
StocksRunner

Discover JNJ Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of JNJ. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our JNJ Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

JNJ Stock trends

JNJ Stock performance

JNJ Stock analysis

JNJ investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

JNJ Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing JNJ

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing JNJ

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.